Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

计划入组 12 人 · 首次发布于 2016 年 10 月 28 日

AB Gait Estim Neurophysiology

计划入组 50 人 · 首次发布于 2024 年 5 月 28 日

Kahook Dual Blade Ab-interno Trabeculotomy Versus ab Externo Viscotrabeculotomy in Primary Congenital Glaucoma

计划入组 60 人 · 首次发布于 2021 年 11 月 10 日

CD40/EpCAM bispecific antibody(Alligator Bioscience AB)

Ab-03

AB-091

Alligator Bioscience AB

Sweden

INFLECTIS BIOSCIENCE

France

Lexaria Bioscience

United States

Beckman Coulter and Rarity Bioscience Partner to Revolutionize Oncology Research with Enhanced Flow Cytometry

AskBio's Gene Therapies AB-1005 and AB-1002 Receive Japan's Pioneering Regenerative Medical Product Designation

Disease Rarity and Clinical Benefits Drive Rare Disease Drug Pricing in Germany's AMNOG System